We are live on ! Find out more
CASC

Cascadian Therapeutics, Inc.
CASC

Delisted

CASC was delisted on the 8th of March, 2018.

Back to rankings

74 hedge funds and large institutions have $110M invested in Cascadian Therapeutics, Inc. in 2014 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 22 increasing their positions, 19 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

214% more call options, than puts

Call options by funds: $2.27M | Put options by funds: $722K

114% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 7

89% more capital invested

Capital invested by funds: $58M → $110M (+$51.6M)

16% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 19

10% more funds holding

Funds holding: 67 → 74 (+7)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
74
Holders Change
+7
Holders Change %
+10.45%
% of All Funds
2.14%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
22
Reduced
19
Closed
7
Calls
$2.27M
Puts
$722K
Net Calls
+$1.54M
Net Calls Change
-$53K

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$6.75M
2
GPP
Great Point Partners
Connecticut
+$2.71M
3
DCM
Driehaus Capital Management
Illinois
+$1.76M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$991K
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$940K

Top Sellers

Rank Fund Capital Flow
1
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
-$2.38M
2
SM
Sabby Management
Florida
-$1.96M
3
First Manhattan
First Manhattan
New York
-$1.42M
4
CI
Cowen Inc
New York
-$616K
5
Group One Trading
Group One Trading
Illinois
-$470K
Name Holding Trade Value Shares
Change 		Change in
Stake
U
26
UBS
Switzerland
$563K +$460K +28,023 +832%
BG
27
BlackRock Group
United Kingdom
$389K +$356K +21,656 New
PAM
28
Panagora Asset Management
Massachusetts
$381K +$349K +21,230 New
OAM
29
Oxford Asset Management
United Kingdom
$366K +$335K +20,374 New
Northern Trust
30
Northern Trust
Illinois
$313K -$17.4K -1,059 -6%
Jane Street
31
Jane Street
New York
$307K +$281K +17,124 New
WMSA
32
Weiss Multi-Strategy Advisers
New York
$299K +$112K +6,838 +70%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$292K +$46.7K +2,844 +21%
SFM
34
Soros Fund Management
New York
$268K +$245K +14,933 New
VKH
35
Virtu KCG Holdings
New York
$216K -$10.9K -664 -5%
Nomura Holdings
36
Nomura Holdings
Japan
$205K +$151K +9,211 +480%
LP
37
LMR Partners
United Kingdom
$183K +$168K +10,202 New
ARTA
38
A.R.T. Advisors
New York
$148K -$37.8K -2,303 -22%
Wells Fargo
39
Wells Fargo
California
$148K +$135K +8,227 +19,588%
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$142K – – –
LTFS
41
Ladenburg Thalmann Financial Services
Florida
$124K +$39.7K +2,419 +54%
US Bancorp
42
US Bancorp
Minnesota
$114K +$105K +6,366 +212,200%
Goldman Sachs
43
Goldman Sachs
New York
$109K +$41.8K +2,545 +73%
JP Morgan Chase
44
JP Morgan Chase
New York
$106K +$97.2K +5,918 New
Citigroup
45
Citigroup
New York
$102K -$2.5K -152 -3%
SKK
46
Shepherd Kaplan Krochuk
Massachusetts
$99K +$90.3K +5,500 New
HK
47
Horizon Kinetics
New York
$97K – – –
Tudor Investment Corp
48
Tudor Investment Corp
Connecticut
$92K -$25K -1,524 -23%
State Street
49
State Street
Massachusetts
$87K – – –
Dimensional Fund Advisors
50
Dimensional Fund Advisors
Texas
$84K – – –
1
2
3 4

CASC Hedge Fund Activity: Q1 2014 in Review

74 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Cascadian Therapeutics, Inc. (CASC) for Q1 2014, worth a combined $110M — up 89% from $58M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new CASC positions and 7 closed out — a net gain of 8 holders — while 22 added to existing stakes and 19 trimmed.

The largest buyer was Franklin Resources, adding an estimated $6.75M. The largest seller was State of Wisconsin Investment Board, exiting entirely with an estimated $2.38M sold.

  • 74 institutional investors held Cascadian Therapeutics, Inc. (CASC) as of Q1 2014, up from 67 in Q4 2013.
  • Funds reported $110M of Cascadian Therapeutics, Inc. stock for Q1 2014, up 89% quarter-over-quarter.
  • 15 funds opened new Cascadian Therapeutics, Inc. positions in Q1 2014 and 7 closed out, a net change of +8 holders.
  • The largest Cascadian Therapeutics, Inc. buyer in Q1 2014 was Franklin Resources, an estimated $6.75M added.
  • The largest Cascadian Therapeutics, Inc. seller in Q1 2014 was State of Wisconsin Investment Board, an estimated $2.38M sold.

Based on aggregated 13F filings for Q1 2014.